Rite Aid (RAD) Tops Q2 EPS by 7c; Cuts FY15 EPS Outlook

Rite Aid (NYSE: RAD) reported Q2 EPS of $0.13, $0.07 better than the analyst estimate of $0.06. Revenue for the quarter came in at $6.5 billion versus the consensus estimate of $6.48 billion.

Same store sales for the quarter increased 4.1 percent over the prior year, consisting of a 1.1 percent increase in front-end sales and a 5.6 percent increase in pharmacy sales.

Rite Aid sees FY15 EPS of $0.22 - $0.33, versus prior guidance of $0.30 - $0.40 and the consensus of $0.34. Sales expected at $26.0 - 26.3 billion, from $26 - $26.5 billion prior.

For earnings history and earnings-related data on Rite Aid (RAD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Vivos Therapeutics posts 35% revenue gain but widens net loss
• SanDisk upgraded at JPMorgan after investor day; shares climb